Results 81 to 90 of about 29,062 (232)

Insulinoma in Patients with Diabetes- A Systematic Review of Previously Reported Cases

open access: yesIndian Journal of Endocrinology and Metabolism
Introduction: Paradoxical co-existence of insulinoma and diabetes is extremely rare. Although a few case reports addressed this association, a comprehensive study elucidating this relationship has been lacking.
Subhankar Chatterjee   +5 more
doaj   +1 more source

A propósito de un caso : paciente con cuadro de disartria de una hora y media de evolución [PDF]

open access: yes, 2017
Insulinoma is a neoplasia of pancreatic β-cells that secretes insulin. It constitutes a rare cause of hypoglycemia. Poor knowledge of this disease is explained by the low incidence, 4 in 1 million people per year. The nonspecific symptoms and its size
Roldán Vásquez, Ana María
core  

Antithymocyte Globulin Plus G-CSF Combination Therapy Leads to Sustained Immunomodulatory and Metabolic Effects in a Subset of Responders With Established Type 1 Diabetes. [PDF]

open access: yes, 2016
Low-dose antithymocyte globulin (ATG) plus pegylated granulocyte colony-stimulating factor (G-CSF) preserves β-cell function for at least 12 months in type 1 diabetes.
Atkinson, Mark A   +14 more
core   +3 more sources

The Risk of Disease Progression of Type 1 Diabetes in First‐Degree Relatives of People With Type 1 Diabetes: Design and Rationale of a Prospective, Longitudinal Study in China

open access: yesDiabetes, Obesity and Metabolism, Volume 28, Issue 6, Page 4610-4618, June 2026.
ABSTRACT Aims In China, information on individuals who test positive for islet autoantibodies (IAb), including single IAb‐positive individuals and those with early‐stage Type 1 diabetes (T1D), and their risk of progression to Stage 3 T1D is limited. The goal of this study is to assess the risk of progression to T1D in first‐degree relatives (FDRs) of ...
Lixin Guo   +14 more
wiley   +1 more source

An insulinoma presenting with hypochondriac delusions and food refusal [PDF]

open access: yes, 2013
The authors report a case of a 68-year-old man with an unrecognized insulinoma manifesting with neuropsychiatric symptoms. For two years, he presented with unspecified behavior changes, autonomic and neuroglycopenic symptoms, which led him to be ...
Cerejeira, J, Renca, S, Santos, G
core   +1 more source

Five Advances in Benign Pancreatic Surgery in the Last 50 Years

open access: yes
World Journal of Surgery, EarlyView.
Stephan B. Dreyer, Rowan W. Parks
wiley   +1 more source

Primary Small Cell Neuroendocrine Carcinoma of the Sublingual Gland Treated With Definitive Chemoradiotherapy: A Case Report

open access: yesClinical Case Reports, Volume 14, Issue 5, May 2026.
ABSTRACT Primary sublingual gland small cell neuroendocrine carcinoma (SCNEC) is extremely rare, with only one prior case reported, and no site‐specific standard of care has been established. We report a case of primary sublingual gland SCNEC treated with definitive concurrent chemoradiotherapy (CRT). A 69‐year‐old man presented with a 21 × 15‐mm right
Taka‐aki Tokura   +10 more
wiley   +1 more source

An unusual cause of hypoglycemia in a middle-aged female after bariatric surgery [PDF]

open access: yes, 2014
Non-insulinoma pancreatogenous hypoglycemia syndrome (NIPHS) is a disorder characterized by postprandial hypoglycemia and islet cell hypertrophy. It is an uncommon complication of weight-loss surgery.
Ahmed Salman   +3 more
core   +1 more source

INSULINOMA MALIGNO

open access: yesRevista de la Facultad de Medicina Humana, 2017
El insulinoma es el tumor neuroendocrino del páncreas más frecuente. Se presenta el caso de un paciente de 54 años de edad. La sintomatología conocida por la disminución severa de la glicemia en el sistema nervioso central, el diagnostico se basó en la evidencia de hipoglicemia, asociado a niveles elevados de insulina.
Herrera-Favian, Pedro Roberto   +2 more
openaire   +4 more sources

Primary Neuroendocrine Carcinoma of the Breast: A Diagnostic Challenge and Case Report

open access: yesCancer Reports, Volume 9, Issue 5, May 2026.
ABSTRACT Background Primary neuroendocrine carcinoma of the breast (NECB) represents an exceedingly rare entity, comprising less than 0.5% of all breast carcinomas and approximately 1% of all neuroendocrine neoplasms. The 2019 WHO classification defines NECB as tumors expressing neuroendocrine markers in > 90% of tumor cells with morphological features
Hamid Zeinali Nezhad   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy